Lessons learned during the development of HumaPen® Memoir™,, aninsulin pen with a memory feature

6Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Insulin pens are developed to address specific needs of diabetes patients for their pens, such as ease of use, portability, and discreetness. Like many consumer-based products, the development of insulin pens can pose significant challenges to the development team in that they must balance substantial accuracy requirements with aesthetic desires. The HumaPen® Memoir™ team learned valuable lessons throughout the development process that may be worth highlighting. A keen understanding of the unmet needs of the patient population and a skillfully planned product generation map are critical to successful device development. A development team must decide whether to use a Quality Functional Deployment or system engineering-based development plan and, additionally, recognize where proof of concept ends and product development begins to maintain a strict timeline for the project. A proficiency in understanding and managing technical risk is critical to ensure a timely and high-quality product launch to the marketplace. © Diabetes Technology Society.

Cite

CITATION STYLE

APA

Breslin, S. D., Ignaut, D. A., & Boyd, D. E. (2010). Lessons learned during the development of HumaPen® MemoirTM,, aninsulin pen with a memory feature. In Journal of Diabetes Science and Technology (Vol. 4, pp. 540–546). SAGE Publications Inc. https://doi.org/10.1177/193229681000400306

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free